glp-1 drugs history GLP-1 Agonists for Obesity: A
Description
GLP-1-based treatments mark a major advancement in managing obesity and type 2 diabetes, offering added benefits for heart and brain health
Understand the timeline
If people on obesity medication are responsible for household food purchases, they may buy different products for family members as well, such as fewer sugary drinks or snacks
Age Group 15.6.8
Patients with Hashimoto's disease who have metabolic indications for GLP-1 therapy (type 2 diabetes or obesity) may benefit from these medications for those specific conditions, but should not expect direct thyroid benefits
